Format
Sort by
Items per page

Send to

Choose Destination

Best matches for probiotic parkinson's disease:

The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson's disease. Barboza JL et al. Expert Opin Pharmacother. (2015)

Use of probiotics for the treatment of constipation in Parkinson's disease patients. Cassani E et al. Minerva Gastroenterol Dietol. (2011)

Emerging drugs for autonomic dysfunction in Parkinson's disease. Perez-Lloret S et al. Expert Opin Emerg Drugs. (2013)

Search results

Items: 1 to 20 of 22

1.

The Effects of Probiotic Supplementation on Gene Expression Related to Inflammation, Insulin and Lipid in Patients with Parkinson's Disease: A Randomized, Double-blind, PlaceboControlled Trial.

Borzabadi S, Oryan S, Eidi A, Aghadavod E, Daneshvar Kakhaki R, Tamtaji OR, Taghizadeh M, Asemi Z.

Arch Iran Med. 2018 Jul 1;21(7):289-295.

PMID:
30041526
2.

Clinical and metabolic response to probiotic administration in people with Parkinson's disease: A randomized, double-blind, placebo-controlled trial.

Tamtaji OR, Taghizadeh M, Daneshvar Kakhaki R, Kouchaki E, Bahmani F, Borzabadi S, Oryan S, Mafi A, Asemi Z.

Clin Nutr. 2018 Jun 1. pii: S0261-5614(18)30203-6. doi: 10.1016/j.clnu.2018.05.018. [Epub ahead of print]

PMID:
29891223
3.

Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.

Caputi V, Giron MC.

Int J Mol Sci. 2018 Jun 6;19(6). pii: E1689. doi: 10.3390/ijms19061689. Review.

4.

Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.

Sun MF, Shen YQ.

Ageing Res Rev. 2018 Aug;45:53-61. doi: 10.1016/j.arr.2018.04.004. Epub 2018 Apr 26. Review.

PMID:
29705121
5.

Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson's Disease.

Houser MC, Chang J, Factor SA, Molho ES, Zabetian CP, Hill-Burns EM, Payami H, Hertzberg VS, Tansey MG.

Mov Disord. 2018 May;33(5):793-804. doi: 10.1002/mds.27326. Epub 2018 Mar 23.

PMID:
29572994
6.

Management of constipation in patients with Parkinson's disease.

Pedrosa Carrasco AJ, Timmermann L, Pedrosa DJ.

NPJ Parkinsons Dis. 2018 Mar 16;4:6. doi: 10.1038/s41531-018-0042-8. eCollection 2018. Review.

7.

Mind-altering with the gut: Modulation of the gut-brain axis with probiotics.

Kim N, Yun M, Oh YJ, Choi HJ.

J Microbiol. 2018 Mar;56(3):172-182. doi: 10.1007/s12275-018-8032-4. Epub 2018 Feb 28. Review.

PMID:
29492874
8.

Microbiota-Brain-Gut Axis and Neurodegenerative Diseases.

Quigley EMM.

Curr Neurol Neurosci Rep. 2017 Oct 17;17(12):94. doi: 10.1007/s11910-017-0802-6. Review.

PMID:
29039142
9.

Recent developments in understanding the role of the gut microbiota in brain health and disease.

Sherwin E, Dinan TG, Cryan JF.

Ann N Y Acad Sci. 2018 May;1420(1):5-25. doi: 10.1111/nyas.13416. Epub 2017 Aug 2. Review.

PMID:
28768369
10.

Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis.

Westfall S, Lomis N, Kahouli I, Dia SY, Singh SP, Prakash S.

Cell Mol Life Sci. 2017 Oct;74(20):3769-3787. doi: 10.1007/s00018-017-2550-9. Epub 2017 Jun 22. Review.

PMID:
28643167
11.

Gut Microbiota, Nitric Oxide, and Microglia as Prerequisites for Neurodegenerative Disorders.

Tse JKY.

ACS Chem Neurosci. 2017 Jul 19;8(7):1438-1447. doi: 10.1021/acschemneuro.7b00176. Epub 2017 Jul 7. Review.

PMID:
28640632
12.

Gut microbiota: Implications in Parkinson's disease.

Parashar A, Udayabanu M.

Parkinsonism Relat Disord. 2017 May;38:1-7. doi: 10.1016/j.parkreldis.2017.02.002. Epub 2017 Feb 7. Review.

PMID:
28202372
13.

The Microbiome-Gut-Brain Axis in Health and Disease.

Dinan TG, Cryan JF.

Gastroenterol Clin North Am. 2017 Mar;46(1):77-89. doi: 10.1016/j.gtc.2016.09.007. Epub 2017 Jan 4. Review.

PMID:
28164854
14.

Gut microbiota: A player in aging and a target for anti-aging intervention.

Vaiserman AM, Koliada AK, Marotta F.

Ageing Res Rev. 2017 May;35:36-45. doi: 10.1016/j.arr.2017.01.001. Epub 2017 Jan 18. Review.

PMID:
28109835
15.

Nonmotor gastrointestinal disorders in older patients with Parkinson's disease: is there hope?

Georgescu D, Ancusa OE, Georgescu LA, Ionita I, Reisz D.

Clin Interv Aging. 2016 Nov 11;11:1601-1608. eCollection 2016.

16.

Probiotics and prebiotic fiber for constipation associated with Parkinson disease: An RCT.

Barichella M, Pacchetti C, Bolliri C, Cassani E, Iorio L, Pusani C, Pinelli G, Privitera G, Cesari I, Faierman SA, Caccialanza R, Pezzoli G, Cereda E.

Neurology. 2016 Sep 20;87(12):1274-80. doi: 10.1212/WNL.0000000000003127. Epub 2016 Aug 19.

PMID:
27543643
17.

The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson's disease.

Barboza JL, Okun MS, Moshiree B.

Expert Opin Pharmacother. 2015;16(16):2449-64. doi: 10.1517/14656566.2015.1086747. Epub 2015 Sep 16. Review.

PMID:
26374094
18.

Glyphosate, pathways to modern diseases III: Manganese, neurological diseases, and associated pathologies.

Samsel A, Seneff S.

Surg Neurol Int. 2015 Mar 24;6:45. doi: 10.4103/2152-7806.153876. eCollection 2015.

19.

Gut/brain axis and the microbiota.

Mayer EA, Tillisch K, Gupta A.

J Clin Invest. 2015 Mar 2;125(3):926-38. doi: 10.1172/JCI76304. Epub 2015 Feb 17. Review.

20.

Emerging drugs for autonomic dysfunction in Parkinson's disease.

Perez-Lloret S, Rey MV, Pavy-Le Traon A, Rascol O.

Expert Opin Emerg Drugs. 2013 Mar;18(1):39-53. doi: 10.1517/14728214.2013.766168. Epub 2013 Feb 1. Review.

PMID:
23373820

Supplemental Content

Loading ...
Support Center